MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-31-2025
Illumina Total Non Current Liabilities 2011-2026 | ILMN
Annual Total Non Current Liabilities Illumina
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 2.04 B | 1.4 B | 1.38 B | 1.23 B | - | 1.15 B | 1.16 B | 894 M | 107 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.04 B | 107 M | 1.17 B |
Total Non Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
23.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
574 K | $ 1.29 | -21.17 % | $ 1.72 M |  USA |
 |
Agilent Technologies
A
|
3.29 B | $ 111.7 | -1.36 % | $ 34 B | USA |
 |
Castle Biosciences
CSTL
|
2.76 M | $ 19.13 | 1.32 % | $ 555 M | USA |
|
Akumin
AKU
|
527 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
2.26 M | $ 15.7 | -3.03 % | $ 475 M | USA |
 |
Aspira Women's Health
AWH
|
3.49 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
134 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
11.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
7.74 M | - | - | $ 562 M |  Britain |
 |
Interpace Biosciences
IDXG
|
10 M | $ 1.76 | -2.22 % | $ 7.79 M | USA |
 |
CareDx, Inc
CDNA
|
17.9 M | $ 19.97 | -2.54 % | $ 1.06 B | USA |
 |
Chembio Diagnostics
CEMI
|
24.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
225 M | $ 93.91 | -2.86 % | $ 6.34 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
4.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
73.8 M | $ 415.27 | -0.93 % | $ 12 B | USA |
 |
Global Cord Blood Corporation
CO
|
2.53 B | - | - | $ 399 M |  China |
 |
Mettler-Toledo International
MTD
|
1.61 B | $ 1 031.64 | -0.99 % | $ 21.3 B |  Schweiz |
 |
Fluidigm Corporation
FLDM
|
131 M | - | 1.08 % | $ 308 M | USA |
 |
Myriad Genetics
MYGN
|
107 M | $ 3.58 | -1.1 % | $ 332 M | USA |
 |
Genetic Technologies Limited
GENE
|
559 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
48.5 M | - | 0.12 % | $ 80.1 M | China |
 |
NeoGenomics
NEO
|
435 M | $ 8.24 | -1.44 % | $ 1.06 B | USA |
 |
DermTech
DMTK
|
865 K | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
39.6 M | $ 18.62 | -1.64 % | $ 417 M | USA |
 |
Charles River Laboratories International
CRL
|
2.35 B | $ 150.85 | -5.3 % | $ 7.48 B | USA |
 |
Natera
NTRA
|
124 M | $ 186.36 | -5.36 % | $ 18.3 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.43 B | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
4.6 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
981 M | - | - | $ 19.8 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.45 B | $ 25.23 | -1.06 % | $ 23.9 B |  Niderland |
 |
Guardant Health
GH
|
91.4 M | $ 94.92 | -3.79 % | $ 11.9 B | USA |
 |
Personalis
PSNL
|
639 K | $ 6.36 | -5.22 % | $ 568 M | USA |
 |
Heska Corporation
HSKA
|
57.9 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
461 M | $ 116.38 | -0.61 % | $ 9.6 B |  Irlanda |
 |
Senseonics Holdings
SENS
|
163 M | $ 5.77 | -0.86 % | $ 241 M | USA |
 |
Soleno Therapeutics
SLNO
|
10.8 M | $ 53.01 | 0.04 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.99 B | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
1.57 M | $ 2.34 | -2.9 % | $ 5.38 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
7.82 B | $ 250.4 | -1.43 % | $ 20.8 B | USA |
 |
Thermo Fisher Scientific
TMO
|
22.5 B | $ 438.34 | -2.2 % | $ 165 B | USA |
 |
Trinity Biotech plc
TRIB
|
106 M | $ 0.57 | -1.59 % | $ 205 M | Irlanda |
 |
Celcuity
CELC
|
69.2 K | $ 137.68 | 2.2 % | $ 6.44 B | USA |
 |
Motus GI Holdings
MOTS
|
2.16 M | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
4.56 M | $ 49.17 | -7.14 % | $ 2.94 B | USA |
 |
Neogen Corporation
NEOG
|
19.6 M | $ 8.19 | -2.85 % | $ 1.78 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.17 B | $ 186.61 | -0.71 % | $ 20.7 B | USA |
 |
Invitae Corporation
NVTA
|
320 M | - | - | $ 21.2 M | USA |